endometrial cancer, fertility sparing treatment, pregnancy, completion hysterectomy
Ovarian cancer, PARP inhibitor, Prognosis, recurrence, Survival
Uterine Cervical Neoplasms, Oligometastasis, Stereotactic Ablative Body Radiotherapy, Programmed Cell Death Ligand 1